Frontlight ResearchEarly access
Liver and biliary tract cancer trials in China
621 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleAI-Assisted Non-Contrast CT for Multi-Cancer Screening
- Where
- Shanghai
- Age
- 18 years and over
- People
- 1,000,000
- Run by
- Guo ShiWei
See details and how to joinNCT06632886 - Phase 2Taking peoplemFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 29
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06607107 - No phaseTaking peoplePostoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 204
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06581315 - Phase 3Taking peopleConcurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 540
- Run by
- Sun Yat-sen University
See details and how to joinNCT06041477 - Phase 2Not yet taking people in ChinaLow-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 43
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06567600 - Phase 2Taking peopleIntra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
- Where
- Guangzhou
- Age
- 18 years to 99 years
- People
- 100
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04770207 - No phaseTaking peopleTriple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 28
- Run by
- Fujian Provincial Hospital
See details and how to joinNCT06561399 - No phaseTaking peopleImage Driven Hepatocellular Carcinoma Invasiveness Evaluation Research
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 500
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT06559761 - Phase 1Taking peopleCT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
- Where
- Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guanzhou, Hangzhou, Shanghai, Shenyang, Tianjin, Wuhan, Zhengzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- CARsgen Therapeutics Co., Ltd.
See details and how to joinNCT06560827 - No phaseTaking peopleAblation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Sun Yat-sen University
See details and how to joinNCT06550921 - No phaseTaking peopleProspective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 1,115
- Run by
- RenJi Hospital
See details and how to joinNCT06519578 - No phaseTaking peopleExploring the Association of Imaging and Tumor Microenvironment in Liver Cancer Using Radiogenomic Approach(Radiogenomics-Liver)
- Where
- Wuhan
- Age
- 18 years and over
- People
- 150
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06536998 - Phase 2Taking peopleAdjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
- Where
- Jinan
- Age
- 18 years and over
- People
- 30
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06454578 - Phase 2Not yet taking people in ChinaSurufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 80
- Run by
- RenJi Hospital
See details and how to joinNCT06531291 - No phaseTaking peopleMicrowave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
- Where
- Beijing
- Age
- 18 years and over
- People
- 1,000
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT06462742 - Phase 2Not yet taking people in ChinaConsolidative Radiotherapy (CSRT) in Patients With Oligometastatic/Locally Advanced Unresectable Bilary Tract Cancer (BTC)
- Where
- Shanghai
- Age
- 18 years and over
- People
- 128
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06502080 - No phaseTaking peopleEfficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 524
- Run by
- West China Hospital
See details and how to joinNCT06341270 - Phase 2Taking peopleAdjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab
- Where
- Fuyang, Hefei
- Age
- 18 years to 80 years
- People
- 45
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06498622 - Phase 2Taking peopleNeoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.
- Where
- Guanzhou
- Age
- 18 years to 75 years
- People
- 90
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06492408 - Phase 2Taking peopleCombined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 38
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT06298968 - Phase 2Taking peopleCheckpoint Inhibitor Combinations Therapy as First Line for HCC Via IT
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 90
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06482801 - Phase 2/3Taking peopleInterventional Software for Multi-immunotherapy of Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06478108 - No phaseTaking peopleBackline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib
- Where
- Zhengzhou
- Age
- 18 years to 75 years
- People
- 22
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06478927 - Phase 3Taking peopleInfusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
- Where
- Guanzhou
- Age
- 18 years to 80 years
- People
- 200
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT03949231 - Phase 1Taking peopleIntratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 50
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT04952272